Press release
Axial Spondyloarthritis Therapeutics Market Size was ~USD 9 Million in 2023, estimated DelveInsight
Discover Key Insights into the Axial Spondyloarthritis Market with DelveInsight's In-Depth Report @ Axial Spondyloarthritis Market Size [https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Axial Spondyloarthritis Market Report
* In November 2024:- UCB Biopharma SRL- A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants With Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis. The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (nr-axSpa).
* As per DelveInsight's estimates, the total diagnosed population of non-radiographic axial spondyloarthritis in the US was around 569,000 cases in 2023.
* Among EU4 and UK countries, Germany had the highest number of prevalent axial spondyloarthritis cases in 2023, followed by Spain.
* The leading Axial Spondyloarthritis Companies such as Janssen Pharmaceuticals, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, and others
* Promising Axial Spondyloarthritis Therapies such as SIMPONI (golimumab), XELJANZ (tofacitinib), Bimekizumab, CC-99677, ABY- 035, Filgotinib, KHK4827, Ixekizumab, Golimumab, etanercept, Secukinumab, SHR0302, Certolizumab Pegol , and others
Stay ahead in the Axial Spondyloarthritis Therapeutics Market with DelveInsight's Strategic Report @ Axial Spondyloarthritis Market Outlook [https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Axial Spondyloarthritis Epidemiology Segmentation in the 7MM
* Total Axial Spondyloarthritis Prevalent Cases
* Total Axial Spondyloarthritis Diagnosed Prevalent Cases
* Axial Spondyloarthritis Gender-specific Cases
* Axial Spondyloarthritis Gene-specific Cases
* Axial Spondyloarthritis Age-specific Cases
* Total Axial Spondyloarthritis Treated Cases
Download the report to understand which factors are driving Axial Spondyloarthritis epidemiology trends @ Axial Spondyloarthritis Prevalence [https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Axial Spondyloarthritis Marketed Drugs
* SIMPONI (golimumab): Janssen Pharmaceuticals
SIMPONI is a human IgG1? monoclonal antibody specific for human tumor necrosis factor-alpha (TNF--a) that exhibits multiple glycoforms. It was created using genetically engineered mice immunized with human TNF, resulting in an antibody with human-derived antibody variable and constant regions. It binds to both the soluble and transmembrane bioactive forms of human TNFa. This interaction prevents the binding of TNFa to its receptors, thereby inhibiting the biological activity of TNFa (a cytokine protein). This molecule is produced by a recombinant cell line cultured by continuous perfusion and is purified by a series of steps that include measures to inactivate and remove viruses.
* XELJANZ (tofacitinib): Pfizer
XELJANZ, a film-coated immediate-release tablet, is the first and only oral JAK inhibitor approved in the European Union for five indications. It is prescribed for adults with active AS who have not responded adequately to conventional therapy and for adults with moderately to severely active RA after failure or intolerance to disease-modifying antirheumatic drugs (DMARDs). Additionally, it is used for adults with active PsA after DMARD failure or intolerance and for adults with moderately to severely active UC who have had an inadequate response, lost response, or were intolerant to conventional therapy or a biologic agent.
Axial Spondyloarthritis Market Outlook
The market size of axial spondyloarthritis in the seven major markets is expected to increase substantially from 2024. The United States accounts for the largest market size of axial spondyloarthritis, in comparison to EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan. Among EU4 and the UK, Germany has the largest market size, followed by Spain, with France having the smallest market size. In 2023, the total market size for axial spondyloarthritis therapies was approximately USD 9 million, with the majority occupied by conventional treatments.
Get In-Depth Knowledge on Axial Spondyloarthritis Market Trends and Forecasts with DelveInsight @ Axial Spondyloarthritis Treatment Market [https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Axial Spondyloarthritis Therapies and Companies
* SIMPONI (golimumab): Janssen Pharmaceuticals
* XELJANZ (tofacitinib): Pfizer
* Bimekizumab: UCB Biopharma
* CC-99677: Celgene
* ABY- 035: Inmagene Biopharmaceuticals
* Filgotinib: Galapagos NV
* KHK4827: Kyowa Kirin Co., Ltd.
* Ixekizumab: Eli Lilly and Company
* Golimumab: Merck Sharp & Dohme LLC
* etanercept: Pfizer
* Bimekizumab: UCB Biopharma
* Secukinumab: Novartis
* SHR0302: Jiangsu HengRui Medicine
* Certolizumab Pegol: UCB Biopharma
Axial Spondyloarthritis Market Drivers
* The introduction of novel products
* Increasing prevalence
* Awareness about the Disease
* Research and development strategies
Axial Spondyloarthritis Market Barriers
* High-cost treatment
* Delay in Diagnosis
* Immunogenicity
* Loss of patent exclusivity
* Availability of generics
* Poor Quality of Life
Unlock Strategic Insights with DelveInsight's Comprehensive Axial Spondyloarthritis Market Report @ Axial Spondyloarthritis Market Drivers and Barriers [https://www.delveinsight.com/sample-request/axial-spondyloarthritis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Axial Spondyloarthritis Market Report
* Coverage- 7MM
* Axial Spondyloarthritis Companies- Janssen Pharmaceuticals, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, and others
* Axial Spondyloarthritis Therapies- SIMPONI (golimumab), XELJANZ (tofacitinib), Bimekizumab, CC-99677, ABY- 035, Filgotinib, KHK4827, Ixekizumab, Golimumab, etanercept, Secukinumab, SHR0302, Certolizumab Pegol, and others.
* Axial Spondyloarthritis Therapeutic Assessment: Axial Spondyloarthritis Current marketed and Lipodystrophy Emerging Therapies
* Axial Spondyloarthritis Market Dynamics: Axial Spondyloarthritis Market drivers and Lipodystrophy Market Barriers
Table of Content
1. Key Insights
2. Report Introduction
3. Axial Spondyloarthritis (axSpA) Market Overview at a Glance
4. Methodology
5. Executive Summary
6. Disease Background and Overview
7. Treatment of Axial Spondyloarthritis (axSpA)
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Market Analysis
12. KOL Views
13. SWOT Analysis
14. Unmet Needs
15. Market Access and Reimbursement
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=axial-spondyloarthritis-therapeutics-market-size-was-usd-9-million-in-2023-estimated-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axial Spondyloarthritis Therapeutics Market Size was ~USD 9 Million in 2023, estimated DelveInsight here
News-ID: 3750299 • Views: …
More Releases from ABNewswire
South Charlotte's Silent Threat: Best Option Restoration Advocates for Professio …
For residents dealing with suspected mold, finding a trusted provider is essential. Searching for "mold removal near me" often leads homeowners to local experts like Best Option Restoration, who offer prompt and thorough inspections. Their team uses advanced tools, such as moisture meters and thermal imaging cameras, to detect hidden mold behind walls, under flooring, or in attics.
Mold growth in homes is often referred to as a "silent threat" because…
Hidden Home Hazard: Best Option Restoration Urges South Charlotte Homeowners to …
The unique climate of the region can exacerbate mold issues, as high humidity provides ideal conditions for spores to thrive. Professional mold remediation South Charlotte involves more than just removing visible mold; it requires addressing the underlying moisture source, containing affected areas to prevent cross-contamination, and using advanced techniques like HEPA filtration and antimicrobial treatments.
In the aftermath of flooding, South Charlotte homeowners often focus on visible water damage, overlooking one…
After the Storm: Best Option Restoration Sees Spike in Calls for Professional Wa …
When storms hit, they often leave a trail of water intrusion that can compromise foundations, walls, and flooring. The immediate priority is to extract standing water and begin the drying process. This is where the value of a dedicated emergency water damage restoration service becomes evident. Best Option Restoration offers 24/7 availability, deploying trained technicians equipped with industrial-grade extractors, air movers, and dehumidifiers.
In the wake of recent severe weather events,…
Why More Ames Residents Trust Pet Medical Center for Emergency Vet Services & Co …
Not all veterinary clinics are equipped to handle exotic animals, but Pet Medical Center stands out as a trusted exotic vet in the area. Birds, reptiles, and small mammals require specialized knowledge, and their team has the training to provide proper diagnostics and treatment. Whether it's a sick guinea pig or an injured lizard, exotic pet owners can trust they're in capable hands.
When a pet emergency strikes, Ames residents need…
More Releases for Axial
Transformative Trends Impacting the Axial Lead Capacitors Market Landscape: Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Axial Lead Capacitors Market Size By 2025?
The market size for axial lead capacitors has seen robust growth in the past years. The market is projected to increase from $0.98 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR)…
Six Axial Simulation Table Market Size Analysis by Application, Type, and Region …
According to Market Research Intellect, the global Six Axial Simulation Table market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The six axial simulation table market is experiencing notable growth due to its expanding use in…
Axial Flow Pump Market Fueled By Growing Freshwater Needs: An Emerging Driver Tr …
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Axial Flow Pump Market?
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Axial Bone Densitometry Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Axial Bone Densitometry Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
Axial bone densitometry market is witnessing significant growth owing to the rising prevalence of osteoporosis and bone-related disorders worldwide. The market encompasses various products…
Axial Extensometers Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Axial Extensometers Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Axial Extensometers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In…
Axial Piston Motor Market
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2100
An axial piston motor is a positive displacement motor that has a number of pistons in a circular array within a cylinder block. Axial piston motor works with a bent axis design or swash plate principle and is available in both variable and fixed displacement designs. The constant displacement type works as a hydraulic motor and the variable displacement type works as a hydraulic pump.
Growing the…
